Menu
Sanofi was one of three drug manufacturers to recently update its contract pharmacy restrictions in response to new state laws.

More Drugmakers Exempt New States from 340B Contract Pharmacy Restrictions

William Newton, Associate Editor/Senior Writer 340B Report Views
Pharmaceutical manufacturers Sanofi, GlaxoSmithKline (GSK) and Viatris are fully or partially exempting additional states from their 340B contract pharmacy restrictions. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Post Navigation

Third Drugmaker Sues Kansas Over Its 340B Contract Pharmacy Access Law

Senate Committee Votes to Increase HRSA Funding, Flat Fund OPA and Chides Drug Manufacturers on 340B Restrictions

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Quick verification required before signup

Site Footer Live